Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
February 4, 2026
Approximately 5 minutes
When to Report Field Safety Corrective Actions in Singapore
When to Report Field Safety Corrective Actions in Singapore
1. Overview
Field Safety Corrective Action (FSCA) refers to any action taken to reduce the risk of using a medical device already placed on the market. Manufacturers are required to report FSCAs to the Health Sciences Authority (HSA) when the action is necessary to address unacceptable risks associated with the device. Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
2. Situations Requiring FSCA Reporting
Report an FSCA to HSA if the corrective action is initiated because:
- The device presents an unacceptable risk to patients, users, or others.
- The device does not meet its performance claims or intended purpose.
- There is a need to reduce risk through actions such as:
- Recall or field safety notice
- Design modification
- Software update
- Labelling or instructions for use change
- Advice to users on specific actions
Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
3. Types of FSCAs
Common FSCAs include:
- Recall — Removal of devices from the market or from use due to safety concerns.
- Field Safety Notice (FSN) — Communication to users about risks and recommended actions without physical removal.
- Design changes — Modifications to the device to eliminate or reduce risk.
- Labelling updates — Changes to warnings, contraindications, or instructions.
All such actions triggered by risk concerns must be reported. Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
4. Reporting Timelines
- Report the FSCA to HSA as soon as possible and no later than 2 working days after initiating the action or becoming aware of the need for it.
- Submit the Field Safety Notice (FSN) or equivalent communication together with the report.
Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
5. Reporting Process
- Submit reports via the HSA online portal or designated forms.
- Include details such as the reason for the FSCA, affected devices (model, serial/lot numbers), risk assessment, and corrective actions.
- Manufacturers must also distribute the FSN to relevant parties in Singapore and provide HSA with distribution records.
Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
6. Important Notes
- Overseas manufacturers must report FSCAs that affect devices supplied in Singapore.
- Failure to report mandatory FSCAs may result in regulatory non-compliance.
- HSA may request additional information or coordinate risk communication.
- Last updated: 31 Dec 2018. Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
7. Related Requirements
Refer to the full Field Safety Corrective Action guidance for details on report content, follow-up actions, and effectiveness monitoring. Source: https://www.hsa.gov.sg/medical-devices/field-safety-corrective-action/when-to-report
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Adverse Event Reporting for Medical Devices in Singapore
Healthcare professionals, manufacturers, importers, and suppliers in Singapore are required to report serious adverse events involving medical devices to HSA within specified timelines to support post-market safety monitoring.
Approximately 5 minutes
Reporting Field Safety Corrective Actions to HSA in Singapore
Manufacturers must submit Field Safety Corrective Action reports to HSA within 2 working days of initiation, including the Field Safety Notice and details of affected devices and corrective measures.
Approximately 5 minutes
Types of Field Safety Corrective Actions for Medical Devices in Singapore
Field Safety Corrective Actions in Singapore include recalls, design modifications, software updates, labelling changes, and user advice to mitigate unacceptable risks associated with marketed medical devices.